◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Vijaya Diagnostic Centre Limited (VIJAYA) Financial History

Name: Vijaya Diagnostic Centre Limited (VIJAYA) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-09-20

Vijaya Diagnostic Centre Limited (VIJAYA) operates in the Diagnostics & Research industry and is headquartered in Hyderabad, India with about 2,507 employees. Its market capitalization is roughly ₹161 billion. In the fiscal year ended 2026-03-31, VIJAYA reported ₹8.1B in revenue and ₹1.7B in net income.

Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India.

Interactive charts & full statements →

VIJAYA Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	₹8.1B	₹6.8B	₹5.5B	₹4.6B	—
Gross Profit	₹7.2B	₹6.0B	₹4.8B	₹4.0B	—
Operating Income (EBIT)	₹2.5B	₹2.0B	₹1.6B	₹1.2B	—
Net Income	₹1.7B	₹1.4B	₹1.2B	₹846M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

VIJAYA Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-06-30	2025-03-31	2024-12-31
Total Revenue	₹2.3B	₹2.2B	₹2.1B	₹1.9B	₹1.7B	—
Gross Profit	₹2.1B	₹1.9B	₹1.8B	₹1.7B	₹1.5B	—
Operating Income (EBIT)	₹734M	₹712M	₹617M	₹526M	₹500M	—
Net Income	₹531M	₹479M	₹432M	₹386M	₹349M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

VIJAYA Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹205M)	(₹103M)	(₹102M)	(₹102M)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

VIJAYA Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹15.1B	₹12.7B	₹9.8B	₹8.5B	—
Total Liabilities	₹5.5B	₹4.7B	₹3.2B	₹3.1B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VIJAYA viewer.

Other Companies in Diagnostics & Research

2359 · WuXi AppTec Co., Ltd. — HK$606 billion
SAILIFE · Sai Life Sciences Limited — ₹340 billion
LALPATHLAB · Dr. Lal PathLabs Limited — ₹317 billion
4544 · H.U. Group Holdings, Inc. — JPY 198 billion
SYNGENE · Syngene International Limited — ₹149 billion
4694 · BML, Inc. — JPY 138 billion
METROPOLIS · Metropolis Healthcare Limited — ₹124 billion
2268 · WuXi XDC Cayman Inc. — HK$98 billion

← VII All “V” companies VIJIFIN →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.